For: |
Tong YF, Lv J, Ying LY, Xu F, Qin B, Chen MT, Meng F, Tu MY, Yang NM, Li YM, Zhang JZ. Seven-day triple therapy is a better choice for |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v21/i46/13073.htm |
Number | Citing Articles |
1 |
Peter H. Katelaris, Anthea L. Katelaris. A prospective evaluation of levofloxacin‐based triple therapy for refractory Helicobacter pylori infection in Australia. Internal Medicine Journal 2017; 47(7): 761 doi: 10.1111/imj.13432
|
2 |
Shivaram Prasad Singh, Vineet Ahuja, Uday C. Ghoshal, Govind Makharia, Usha Dutta, Showkat Ali Zargar, Jayanthi Venkataraman, Amit Kumar Dutta, Asish K Mukhopadhyay, Ayaskanta Singh, Babu Ram Thapa, Kim Vaiphei, Malathi Sathiyasekaran, Manoj K. Sahu, Niranjan Rout, Philip Abraham, Prakash Chandra Dalai, Pravin Rathi, Saroj K. Sinha, Shobna Bhatia, Susama Patra, Ujjala Ghoshal, Ujjal Poddar, Venigalla Pratap Mouli, Vikram Kate. Management of Helicobacter pylori infection: The Bhubaneswar Consensus Report of the Indian Society of Gastroenterology. Indian Journal of Gastroenterology 2021; 40(4): 420 doi: 10.1007/s12664-021-01186-4
|
3 |
Soichiro Sue, Marina Ogushi, Isao Arima, Hirofumi Kuwashima, Satoshi Nakao, Makoto Naito, Kazuo Komatsu, Hiroaki Kaneko, Toshihide Tamura, Tomohiko Sasaki, Masaaki Kondo, Wataru Shibata, Shin Maeda. Vonoprazan‐ vs proton‐pump inhibitor‐based first‐line 7‐day triple therapy for clarithromycin‐susceptible Helicobacter pylori: A multicenter, prospective, randomized trial. Helicobacter 2018; 23(2) doi: 10.1111/hel.12456
|
4 |
Anthony O'Connor, Wolfgang Fischbach, Javier P. Gisbert, Colm O'Morain. Treatment of Helicobacter pylori infection 2016. Helicobacter 2016; 21(S1): 55 doi: 10.1111/hel.12342
|
5 |
Jian‐Wei Yun, Cui Wang, Yi Yu, Hui‐Mei Xu, Ling‐Zhu Gou, Xiao‐Li Li, Gui‐Rong Yi, Yi‐Ming Lin, Ti‐Yun Han, De‐Kui Zhang. High‐dose amoxicillin‐proton pump inhibitor dual therapy as first‐line treatment for Helicobacter pylori infection in Northwest China: A prospective, randomised controlled trial. British Journal of Clinical Pharmacology 2023; 89(1): 232 doi: 10.1111/bcp.15488
|
6 |
Jiaoe Chen, Liping Ye, Liangmin Jin, Xuehua Xu, Peisong Xu, Xianjun Wang, Hongzhang Li. Application of next-generation sequencing to characterize novel mutations in clarithromycin-susceptible Helicobacter pylori strains with A2143G of 23S rRNA gene. Annals of Clinical Microbiology and Antimicrobials 2018; 17(1) doi: 10.1186/s12941-018-0259-8
|
7 |
Jie Pan, Zhengchao Shi, Dingsai Lin, Ningmin Yang, Fei Meng, Lang Lin, Zhencheng Jin, Qingjie Zhou, Jiansheng Wu, Jianzhong Zhang, Youming Li. Is tailored therapy based on antibiotic susceptibility effective ? a multicenter, open-label, randomized trial. Frontiers of Medicine 2020; 14(1): 43 doi: 10.1007/s11684-019-0706-8
|
8 |
Yunzhi Zou, Xing Qian, Xiaoqun Liu, YanPing Song, Conghua Song, Shuang Wu, Ying An, Rui Yuan, Youhua Wang, Yong Xie. The effect of antibiotic resistance on Helicobacter pylori eradication efficacy: A systematic review and meta‐analysis. Helicobacter 2020; 25(4) doi: 10.1111/hel.12714
|
9 |
Yao Chen, Qingyi Liu, Fulian Hu, Jizheng Ma. Identifying the best regimen for primary eradication of Helicobacter pylori: analysis of 240 cases. MicrobiologyOpen 2020; 9(11) doi: 10.1002/mbo3.1120
|
10 |
Huo-Ye Gan, Tie-Li Peng, You-Ming Huang, Kai-Hua Su, Lin-Li Zhao, Li-Ya Yao, Rong-Jiao Yang. Efficacy of two different dosages of levofloxacin in curing Helicobacter pylori infection: A Prospective, Single-Center, randomized clinical trial. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-27482-2
|
11 |
Alessia Savoldi, Elena Carrara, David Y. Graham, Michela Conti, Evelina Tacconelli. Prevalence of Antibiotic Resistance in Helicobacter pylori: A Systematic Review and Meta-analysis in World Health Organization Regions. Gastroenterology 2018; 155(5): 1372 doi: 10.1053/j.gastro.2018.07.007
|
12 |
Reka Borka Balas, Lorena Elena Meliț, Cristina Oana Mărginean. Current Worldwide Trends in Pediatric Helicobacter pylori Antimicrobial Resistance. Children 2023; 10(2): 403 doi: 10.3390/children10020403
|
13 |
Salma Burayzat, Mohammad Al-Tamimi, Mohammad Barqawi, Mustafa Sabri Massadi, Jumanah Abu-Raideh, Hadeel Albalawi, Ashraf I. Khasawneh, Nisreen Himsawi, Maha Barber. Antimicrobial Resistance Molecular Mechanisms of Helicobacter pylori in Jordanian Children: A Cross-Sectional Observational Study. Antibiotics 2023; 12(3): 618 doi: 10.3390/antibiotics12030618
|